Rockefeller Capital Management L.P. Immuno Gen, Inc. Transaction History

Rockefeller Capital Management L.P.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$4.48 - $6.47 $797 - $1,151	178 Added 39.29%	631 $3,000
Q2 2022 Aug 12, 2022	SELL	$3.15 - $5.76 $3,127 - $5,719	-993 Reduced 68.67%	453 $2,000
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $817 - $1,436	192 Added 15.31%	1,446 $6,000
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $3,591 - $5,670	756 Added 151.81%	1,254 $9,000
Q3 2021 Nov 12, 2021	SELL	$5.02 - $6.59 $843 - $1,107	-168 Reduced 25.23%	498 $2,000
Q2 2021 Aug 10, 2021	BUY	$5.79 - $8.6 $202 - $301	35 Added 5.55%	666 $4,000
Q1 2021 May 11, 2021	BUY	$6.5 - $10.53 $1,644 - $2,664	253 Added 66.93%	631 $5,000
Q4 2020 Feb 12, 2021	SELL	$3.7 - $7.66 $77 - $160	-21 Reduced 5.26%	378 $2,000
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $10 - $14	-3 Reduced 0.75%	399 $1,000
Q2 2020 Aug 12, 2020	BUY	$3.32 - $5.34 $19 - $32	6 Added 1.52%	402 $2,000
Q1 2020 May 12, 2020	SELL	$2.12 - $6.8 $816 - $2,618	-385 Reduced 49.3%	396 $1,000
Q4 2019 Feb 07, 2020	SELL	$2.25 - $5.8 $245 - $632	-109 Reduced 12.25%	781 $4,000
Q3 2019 Nov 12, 2019	SELL	$2.22 - $3.39 $224 - $342	-101 Reduced 10.19%	890 $2,000
Q2 2019 Aug 09, 2019	SELL	$1.8 - $3.3 $8,670 - $15,896	-4,817 Reduced 82.94%	991 $2,000
Q1 2019 May 10, 2019	BUY	$2.41 - $5.91 $13,997 - $34,325	5,808 New	5,808 $16,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.